In the study conducted by doctor Carlos Carvalho, at the request of the Minister of Health, Marcelo Queiroga, the conclusion is that drugs such as azithromycin and hydroxychloroquine “have not shown clinical benefit.
Therefore, should not be used in the outpatient treatment of patients with suspected or diagnosed Covid-19”. The analysis also does not indicate the use of ivermectin, nitazoxanide, anticoagulants and convalescent plasma in treatment.
To support the rejection, Angotti stated that the decisions were taken in a political context , marked by “inadequacies, weaknesses and ethical risks”.
“There was intense scrutiny and political harassment, unprecedented within the scope of Conitec and fraught with some misunderstandings regarding the institutional role of this advisory body”.
Scientific immaturity was another argument used. “The scientific scenario has not reached the same degree of scientific maturity observed in non-emergency situations opportunely evaluated by Conitec”.
In the secretary’s assessment, the suggested guidelines could interfere with medical autonomy and that the decision comes from the “need not to miss the opportunity to save lives”.
About the Covid kit, the note that supports the rejection says that the expression was never recognized and used by the Ministry of Health. “There was no evaluation of a treatment kit or something similar.
” What happened, in the justification of the folder, was that the “combination of drugs was evaluated (hydroxychloroquine with azithromycin), still with very incipient evidence”.
“This element does not impact the technical evaluation of the material produced by the Elaboration Group, but warns against a possible misunderstanding of the present context.”
Without the approved guidelines, the recommendation of using drugs to treat patients with Covid-19 remains open, even if they have not been proven effective.
Conitec advised against the use of such drugs, precisely because they had no proven benefits. The false sense of security brought about by the use of drugs was another point made by the members of the commission.
The Ministry of Health rejected all the protocols suggested by Conitec (Commission for the Incorporation of Technologies to the SUS) containing the Brazilian Guidelines for Outpatient Drug Treatment of the Patient with Covid-19.
The decision, signed by the Secretary of Science, Technology, Innovation and Strategic Inputs of the Ministry of Health, Hélio Angotti Neto, was published in the DOU (Official Journal of the Union) this Friday (21).
The documents were prepared by the committee that integrates the ministry itself and is formed by representatives of the most important institutions linked to health and by technicians from the ministry.
In December, the group approved the report that rejects the Covid kit in patients who are not hospitalized.